Photoacoustic Imaging
We have a novel high-resolution preclinical photoacoustic scanner, based upon on a highly sensitive optical ultrasound detector developed in UCL Department of Medical Physics & Biomedical Engineering.
Location
Paul O'Gorman Building, Bloomsbury.
Available to
Academic and industry collaborators.
Prices
From £140 per hour.
Hire our facilities
We welcome expressions of interest for preclinical imaging. Find out how to make a booking.
Working with CABI
What is photoacoustic imaging used for?
Photoacoustic imaging is a new biomedical imaging modality based on the use of laser-generated ultrasound. It is one of the most exciting imagining techniques to have emerged in recent years.
It relies upon the absorption of low energy nanosecond pulses of visible or near infrared laser light by specific tissue chromophores to excite broadband ultrasound waves.
These waves are encoded with the optical properties of the tissue. By recording them over the tissue surface using an array of ultrasound receivers, a 3D absorption-based image can be reconstructed.
Core advantages of photoacoustic imaging
By encoding optical absorption onto acoustic waves, it avoids the penetration depth/spatial resolution limitations of purely optical imaging techniques such as light microscopy or diffuse optical tomography that arise from the strong optical scattering of tissue.
At the same time, it retains the high molecular based contrast and spectral specificity of optical methods enabling visualisation of anatomical features indistinguishable with other imaging modalities such as ultrasound.
CABI's Photoacoustic Scanner
Our Centre for Advanced Biomedical Imaging (CABI) has a novel high resolution preclinical photoacoustic scanner, based upon on a highly sensitive optical ultrasound detector developed in the UCL Department of Medical Physics and Biomedical Engineering.
The high sensitivity of the detector combined with novel image reconstruction algorithms enables the acquisition of 3D non-invasive in vivo images at depths approaching 1cm with sub 100µm resolution, making the scanner a powerful preclinical imaging tool.
Using the scanner, the strong optical absorption of endogenous haemoglobin in tissue has been exploited for studying processes characterised by changes in the structure and function of the vasculature.
Examples of such studies include investigating tumour vascular development in whole subcutaneous tumours (see figure 1) as well as the response of tumours to vascular targeted therapy, in a manner not previously possible with existing imaging modalities.
Other studies that have been undertaken include investigations into the vascularisation of tissue engineered scaffolds, changes to vascular architecture in mouse models of kidney disease and embryo development.
In addition, exogenous contrast, in the form of targeted contrast agents or genetically expressed absorbers have been used to study processes at a molecular level.
An example is the in vivo imaging of genetically encoded contrast to visualise cell populations (see figure 2).
